Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples